Stenzel J P, Green T P, Fuhrman B P, Carlson P E, Marchessault R P
Department of Pediatrics, University of Minnesota, Minneapolis 55455.
J Pediatr. 1989 Mar;114(3):411-5. doi: 10.1016/s0022-3476(89)80559-1.
In a prospective, 45-month study, we compared the complication rates of percutaneously placed femoral and nonfemoral central venous catheters in critically ill pediatric patients. Forty-one percent of the 395 central venous catheters placed during this interval were femoral. Noninfectious complications were recognized for 2.5% of femoral catheters and 2.1% of nonfemoral catheters. Only three complications occurred with catheter insertion, all during nonfemoral attempts. Systemic infections that were possibly attributable to the central venous catheter were found in 3.7% of patients with femoral catheters and 7.3% of those with nonfemoral catheters. Femoral venous catheterization offers several practical advantages for central access over other sites. The low incidence of complications documented in this study suggests that the femoral vein is the preferred site in most critically ill children when central venous catheterization is indicated.
在一项为期45个月的前瞻性研究中，我们比较了危重症儿科患者经皮放置的股静脉和非股静脉中心静脉导管的并发症发生率。在此期间放置的395根中心静脉导管中，41%为股静脉导管。股静脉导管的非感染性并发症发生率为2.5%，非股静脉导管为2.1%。仅在导管插入过程中出现了3例并发症，均发生在非股静脉置管尝试时。股静脉导管相关的全身感染发生率在股静脉导管患者中为3.7%，在非股静脉导管患者中为7.3%。与其他部位相比，股静脉置管在中心静脉通路方面具有几个实际优势。本研究记录的低并发症发生率表明，在大多数需要进行中心静脉置管的危重症儿童中，股静脉是首选部位。
